Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to -$3.7 billion.

  • Sanofi's Income from Continuing Operations fell 22197.68% to -$3.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $12.5 billion, marking a year-over-year increase of 386.43%. This contributed to the annual value of $9.4 billion for FY2025, which is 1329.39% down from last year.
  • Latest data reveals that Sanofi reported Income from Continuing Operations of -$3.7 billion as of Q4 2025, which was down 22197.68% from $10.9 billion recorded in Q3 2025.
  • Sanofi's 5-year Income from Continuing Operations high stood at $12.2 billion for Q4 2022, and its period low was -$3.7 billion during Q4 2025.
  • Moreover, its 5-year median value for Income from Continuing Operations was $3.1 billion (2025), whereas its average is $3.8 billion.
  • As far as peak fluctuations go, Sanofi's Income from Continuing Operations surged by 412553.91% in 2022, and later plummeted by 22197.68% in 2025.
  • Over the past 5 years, Sanofi's Income from Continuing Operations (Quarter) stood at $289.9 million in 2021, then soared by 4125.54% to $12.2 billion in 2022, then decreased by 10.54% to $11.0 billion in 2023, then tumbled by 72.21% to $3.0 billion in 2024, then tumbled by 221.98% to -$3.7 billion in 2025.
  • Its last three reported values are -$3.7 billion in Q4 2025, $10.9 billion for Q3 2025, and $2.1 billion during Q2 2025.